Director, Regulatory Affairs
Mr. Mike Winegar has over thirty years of experience in global medical device regulatory affairs, regulatory compliance, quality assurance, and clinical research, with an emphasis on neurovascular, cardiovascular, and peripheral vascular technologies. Mr. Winegar guides the Tissue Genesis regulatory affairs activities.
Mr. Winegar is also Director of the Masters of Science in Regulatory Science program for the University of St. Thomas, in St. Paul, Minnesota. Mr. Winegar has held senior leadership positions with several large and small medical device companies, including Boston Scientific, ev3 (now part of Medtronic/Covidien), Enpath Medical (now part of Greatbatch), Myocor, and Kips Bay Medical.